查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1917795

医疗保健电子知情同意市场－2026-2031年预测

eConsent in Healthcare Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 150 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计医疗保健电子同意市场将从 2025 年的 651,034,000 美元增长到 2031 年的 1,224,730,000 美元，复合年增长率为 11.11%。

医疗保健电子知情同意市场代表着病患知情同意管理方式的根本性转变，它从基于纸本的行政流程转向融入病人参与和临床工作流程的数位化元素。电子知情同意是指利用数位平台取得病患对医疗程序、治疗或研究参与的知情同意，该平台用于呈现资讯、确认理解并取得签名。在医疗保健领域更广泛的数位转型、不断变化的法规以及电子知情同意在提高营运效率和以患者为中心的护理方面已被证实具有的价值的推动下，该市场正经历着稳步增长。

主要成长要素

它具备多项强大的优势，可加速医疗机构的采用。电子知情同意平台透过影片、测验和分层资讯等互动式多媒体元素，提升病患的理解和参与度，这些元素已被证明比静态纸本表格更能有效提高理解力。对于医疗机构而言，知情同意书的数位化显着提高了营运效率，因为它消除了与列印、储存和管理纸本文件相关的成本和后勤负担。与电子健康记录 (EHR) 系统的整合实现了知情同意书的无缝记录和即时搜寻，从而简化了临床工作流程并减少了行政工作。此外，电子知情同意还支持远距收集知情同意，这对于扩大患者就医管道、支持远端医疗倡议以及实现不受地域限制的临床试验参与至关重要。

医疗保健生态系统中数位科技的日益普及是推动市场发展的因素。该行业正在进行的数位革命，强调利用技术改进医疗服务和营运流程，为电子知情同意书的推广应用创造了理想的环境。电子知情同意书取代了纸本工作流程，符合数位化和自动化行政任务的策略性倡议，从而提高了数据的准确性、安全性和可近性。

政府的支持性法规和指导方针为市场扩张提供了关键框架。主要市场的监管机构已发布指南，建议在临床护理和研究中使用电子系统来取得知情同意。这些指南使电子知情同意的使用合法化，明确了合规要求，并鼓励医疗服务提供者和研究赞助商采用标准化的数位化解决方案。这种监管核准对于建立机构信任和加速采购决策至关重要。

在临床试验中，电子知情同意书（eConsent）正日益成为招募、促进和留住受试者的重要工具。透过以引人入胜、易于理解的方式呈现复杂的试验讯息，受试者能够更深入地了解通讯协定、风险和益处。文件管理、远端註册和监管审核效率的提升正在改变试验运作方式，使得电子知情同意书成为申办方和合约研究组织（CRO）提升研究效率和资料品质的策略性投资。

市场挑战与限制因素

儘管成长要素强劲，但仍有一些限制阻碍市场扩张。其中一个主要挑战是，将电子知情同意平台与现有医疗IT基础设施（例如电子健康记录（EHR）和临床试验管理系统）整合存在技术和营运方面的难题。确保无缝互通性通常需要大量的IT资源和周详的计划管理。

数位无障碍和数位素养方面也存在障碍。对于某些患者群体，例如老年人或技术能力有限的人，数位知情同意流程可能具有挑战性。因此，电子知情同意系统必须具备强大的无障碍功能，并提供其他选择，例如当面或辅助式数位知情同意，以确保公平获取资讯并遵守知情同意原则。此外，依赖供应商开发和维护平台可能会使部署计划和后续系统管理变得复杂。

区域市场动态

预计北美将占据全球市场的重要份额。这一主导地位归功于该地区医疗保健领域数位技术的高普及率、成熟且活跃的临床试验体系，以及完善的医疗设施和研究机构基础设施。此外，主要电子知情同意软体供应商的存在以及积极推动数位知情同意的法规环境也进一步促进了技术的普及。这些因素共同造就了电子知情同意解决方案需求和创新的集中中心。

竞争格局

竞争格局的特点是，专业技术供应商提供基于云端的平台，以满足医疗保健和临床研究的严格要求。主要企业凭藉深厚的领域专业知识、与电子健康记录 (EHR) 和临床试验平台等关键系统的整合能力以及对合规性的重视而脱颖而出。解决方案涵盖从生命科学领域全面的内容和资料管理套件到用于临床试验文件管理和病人参与的特定工作流程平台。在这个市场取得成功取决于能否展现安全性、可靠性以及对医护人员和病患都友善的使用者体验。

总之，医疗保健电子知情同意市场正从单纯的便利措施发展成为数位健康策略的核心要素。其成长与整个医疗保健产业向数位化、病患赋权和营运效率提升的转型密不可分。产业专家关注的重点在于开发真正可互通的平台，最大限度地减少整合负担；为不同患者群体设计包容且易于使用的使用者体验；以及不断适应全球市场不断变化的监管标准。从长远来看，电子知情同意将成为医疗服务的标准流程，是现代临床实践和研究的重要组成部分。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料（2021-2025 年）和预测资料（2026-2031 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

5. 按流程类型分類的医疗保健电子同意市场

  • 介绍
  • 偏僻的
  • 面对面

6. 按媒体类型分類的医疗保健电子同意市场

  • 介绍
  • 智慧型手机
  • 平板电脑
  • 其他的

第七章：按应用分類的医疗保健电子同意市场

  • 介绍
  • 临床试验和医疗程序
  • 医疗

第八章：按类型分類的医疗保健电子同意市场

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十章：公司简介

  • Veeva Systems Inc.
  • Concentric Health Ltd
  • Florence Healthcare
  • 5thPort, LLC
  • Cloudbyz
  • Calysta
  • Interlace Health
  • Thieme Compliance GmbH
  • Medable Inc
  • Signant Health

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061615769

eConsent In Healthcare Market is forecasted to rise at a 11.11% CAGR, reaching USD 1224.73 million in 2031 from USD 651.034 million in 2025.

The eConsent in healthcare market represents a fundamental shift in the administration of patient consent, moving from a paper-based, administrative task to an integrated, digital component of patient engagement and clinical workflow. eConsent refers to the electronic process of obtaining and documenting a patient's informed permission for medical procedures, treatments, or research participation, utilizing digital platforms to present information, verify comprehension, and capture signatures. This market is experiencing steady growth, driven by the broader digital transformation of healthcare, regulatory evolution, and the demonstrated value of eConsent in improving operational efficiency and patient-centric care.

Primary Growth Catalysts

Multiple compelling benefits are accelerating adoption across healthcare settings. eConsent platforms enhance patient comprehension and engagement through interactive multimedia elements, such as videos, quizzes, and layered information, which are proven to improve understanding compared to static paper forms. For healthcare organizations, the digitization of consent generates significant operational efficiencies by eliminating the costs and logistical burdens associated with printing, storing, and managing physical documents. Integration with Electronic Health Record (EHR) systems enables seamless documentation and immediate retrieval of consent forms, streamlining clinical workflows and reducing administrative overhead. Furthermore, eConsent facilitates remote consent acquisition, which is critical for expanding patient access, supporting telehealth initiatives, and enabling participation in clinical trials without geographic constraints.

The increased implementation of digital technology across the healthcare ecosystem serves as a foundational market driver. The sector's ongoing digital revolution, emphasizing the use of technology to improve care delivery and operational processes, creates a natural environment for eConsent adoption. By replacing paper-based workflows, eConsent aligns with strategic initiatives to digitize and automate administrative functions, thereby enhancing data accuracy, security, and accessibility.

Supportive government regulations and guidance are providing a critical framework for market expansion. Regulatory bodies in key markets have issued guidelines endorsing the use of electronic systems for obtaining informed consent in both clinical care and research. These directives validate the use of eConsent, clarify compliance requirements, and encourage healthcare providers and research sponsors to adopt standardized digital solutions. This regulatory endorsement is crucial for building institutional confidence and accelerating procurement decisions.

Within clinical trials, eConsent is becoming an increasingly vital tool for enhancing participant recruitment, comprehension, and retention. The ability to present complex trial information in an engaging, accessible format improves participant understanding of protocols, risks, and benefits. The efficiency gains in document management, remote enrollment, and regulatory auditing are transforming trial operations, making eConsent a strategic investment for sponsors and Contract Research Organizations (CROs) aiming to streamline studies and improve data quality.

Market Challenges and Constraints

Despite strong growth drivers, several restraints temper market expansion. A significant challenge is the technical and operational difficulty of integrating eConsent platforms with existing healthcare IT infrastructure, such as EHRs and clinical trial management systems. Successful implementation often requires substantial IT resources and careful project management to ensure seamless interoperability.

The market also faces hurdles related to digital accessibility and literacy. Certain patient populations, including older adults or those with limited technological proficiency, may find digital consent processes challenging. This necessitates that eConsent system designs incorporate robust accessibility features and provide alternative pathways, such as in-person or assisted digital consent, to ensure equitable access and maintain compliance with informed consent principles. Furthermore, reliance on third-party vendors for platform development and maintenance can lead to complexities in deployment timelines and ongoing system management.

Geographic Market Dynamics

North America is projected to hold a significant share of the global market. This leadership position is attributed to the region's higher rate of digital technology adoption in healthcare, a mature and active clinical trials sector, and a well-established infrastructure of healthcare facilities and research institutions. The presence of leading eConsent software providers and a regulatory environment that has actively provided guidance on digital consent further catalyzes adoption. These factors combine to create a concentrated hub of demand and innovation for eConsent solutions.

Competitive Landscape

The competitive environment features specialized technology providers offering cloud-based platforms tailored for the rigorous demands of healthcare and clinical research. Key companies differentiate themselves through deep domain expertise, the ability to integrate with critical systems like EHRs and clinical trial platforms, and a focus on regulatory compliance. Solutions range from comprehensive content and data management suites for life sciences to specific workflow platforms for managing clinical trial documentation and patient engagement. Success in this market is contingent on demonstrating security, reliability, and a user-friendly experience for both healthcare professionals and patients.

In conclusion, the eConsent in healthcare market is evolving from a novel convenience to a core component of digital health strategy. Its growth is inextricably linked to the sector's broader move towards digitization, patient empowerment, and operational efficiency. For industry experts, the critical focus areas are the development of truly interoperable platforms that minimize integration burden, the design of inclusive and accessible user experiences for diverse patient populations, and the continuous alignment with evolving regulatory standards across global markets. The long-term trajectory points to eConsent becoming an embedded standard of care, essential for modern clinical practice and research.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

eConsent in Healthcare Market Segmentation

  • By Process Type
  • Remote
  • In-Person
  • By Media Type
  • Smartphone
  • Tablets
  • Others
  • By Application
  • Clinical Trials & Procedures
  • Medical Treatment
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ECONSENT IN HEALTHCARE MARKET BY PROCESS TYPE

  • 5.1. Introduction
  • 5.2. Remote
  • 5.3. In-Person

6. ECONSENT IN HEALTHCARE MARKET BY MEDIA TYPE

  • 6.1. Introduction
  • 6.2. Smartphone
  • 6.3. Tablets
  • 6.4. Others

7. ECONSENT IN HEALTHCARE MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Clinical Trials & Procedures
  • 7.3. Medical Treatment

8. ECONSENT IN HEALTHCARE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Veeva Systems Inc.
  • 10.2. Concentric Health Ltd
  • 10.3. Florence Healthcare
  • 10.4. 5thPort, LLC
  • 10.5. Cloudbyz
  • 10.6. Calysta
  • 10.7. Interlace Health
  • 10.8. Thieme Compliance GmbH
  • 10.9. Medable Inc
  • 10.10. Signant Health

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations